UA41915C2 - Agent for inhibiting proliferation and migration of vascular smooth muscles in mammals - Google Patents

Agent for inhibiting proliferation and migration of vascular smooth muscles in mammals

Info

Publication number
UA41915C2
UA41915C2 UA95083997A UA95083997A UA41915C2 UA 41915 C2 UA41915 C2 UA 41915C2 UA 95083997 A UA95083997 A UA 95083997A UA 95083997 A UA95083997 A UA 95083997A UA 41915 C2 UA41915 C2 UA 41915C2
Authority
UA
Ukraine
Prior art keywords
mammals
migration
agent
vascular smooth
inhibiting proliferation
Prior art date
Application number
UA95083997A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Іліот Х. ОЛСТАЙН
Илиот Х. Олстайн
Original Assignee
Боерінгер Маннхайм Фармасьютікалз Корпорейшн-Смітклайн Бічам Корпорейшн Лімітед Партнершіп №1
Берингер Маннхайм Фармасьютикалз Корпорейшн-Смитклайн Бичам Корпорейшн Лимитед Партнершип №1
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/026,892 external-priority patent/US5308862A/en
Application filed by Боерінгер Маннхайм Фармасьютікалз Корпорейшн-Смітклайн Бічам Корпорейшн Лімітед Партнершіп №1, Берингер Маннхайм Фармасьютикалз Корпорейшн-Смитклайн Бичам Корпорейшн Лимитед Партнершип №1 filed Critical Боерінгер Маннхайм Фармасьютікалз Корпорейшн-Смітклайн Бічам Корпорейшн Лімітед Партнершіп №1
Publication of UA41915C2 publication Critical patent/UA41915C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

The use of Carvedilol of formula for inhibiting proliferation and migration of the vascular smooth muscles in the mammals.
UA95083997A 1993-03-05 1993-08-27 Agent for inhibiting proliferation and migration of vascular smooth muscles in mammals UA41915C2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/026,892 US5308862A (en) 1993-03-05 1993-03-05 Use of, and method of treatment using, carbazolyl-(4)-oxypropanolamine compounds for inhibition of smooth muscle cell proliferation
PCT/US1993/002062 WO1994020096A1 (en) 1993-03-05 1993-03-05 Method of employing carbazolyl-(4)-oxypropanolamine compounds for inhibition of smooth muscle cell proliferation
PCT/US1993/008019 WO1994020097A1 (en) 1993-03-05 1993-08-27 Use of, and method of treatment using, carbazolyl-(4)-oxypropanolamine compounds for inhibition of smooth muscle cell proliferation

Publications (1)

Publication Number Publication Date
UA41915C2 true UA41915C2 (en) 2001-10-15

Family

ID=26701782

Family Applications (1)

Application Number Title Priority Date Filing Date
UA95083997A UA41915C2 (en) 1993-03-05 1993-08-27 Agent for inhibiting proliferation and migration of vascular smooth muscles in mammals

Country Status (7)

Country Link
EP (1) EP0746315A4 (en)
JP (1) JPH08508013A (en)
AU (1) AU679462B2 (en)
NO (1) NO307865B1 (en)
RU (1) RU2147433C1 (en)
UA (1) UA41915C2 (en)
WO (2) WO1994020096A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2815926A1 (en) * 1978-04-13 1979-10-18 Boehringer Mannheim Gmbh NEW CARBAZOLYL- (4) -OXY-PROPANOLAMINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
DE3319027A1 (en) * 1983-05-26 1984-11-29 Boehringer Mannheim Gmbh, 6800 Mannheim METHOD FOR PRODUCING OPTICALLY ACTIVE CARBAZOL DERIVATIVES, NEW R- AND S-CARBAZOL DERIVATIVES, AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
US4970227A (en) * 1984-11-20 1990-11-13 Burroughs Wellcome Co. Carbazole derivatives

Also Published As

Publication number Publication date
AU5092393A (en) 1994-09-26
JPH08508013A (en) 1996-08-27
EP0746315A1 (en) 1996-12-11
EP0746315A4 (en) 1999-01-07
WO1994020097A1 (en) 1994-09-15
NO307865B1 (en) 2000-06-13
AU679462B2 (en) 1997-07-03
RU2147433C1 (en) 2000-04-20
NO953480D0 (en) 1995-09-04
NO953480L (en) 1995-11-03
WO1994020096A1 (en) 1994-09-15

Similar Documents

Publication Publication Date Title
MX9700538A (en) Use of droloxifene for the treatment of cardiovascular diseases.
MX9707570A (en) USE OF 'alpha'1L AGONISTS IN THE TREATMENT OF INCONTINENCE.
GEP20074251B (en) N-oxycarbonyl substituted 5'- deoxy-5-fluorocytidines
MY106272A (en) Use of 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine derivatives in the treatment of psychosis, inflammation and as immunosuppressants.
HU9502587D0 (en) Use of, and method of treatment using, carbazolyl-(4)-oxypropanolamine compounds for inhibition of smooth muscle cell proliferation
PL316658A1 (en) Novel application of serotonin antagonists
PL323825A1 (en) Peptidyloheterocycli compounds useful in treating diorders associated with thrombosin
EP0659769A3 (en) Agent for promoting the proliferation of bifidobacterium.
EP0717592A4 (en) Method and composition for the treatment of apathy-amotivation syndrome
GR3035725T3 (en) Polyamine compounds for treating vascular proliferative disorders
MY111201A (en) New imidazopyridines
EP0594410A3 (en) Treatment of rubber articles.
EP0475434A3 (en) Polymer composition and its use
PH31600A (en) Methods of inhibiting atrophy of the skin and vagina.
EP0596962A4 (en) Therapeutic compositions and methods.
WO1991018027A3 (en) Compounds
ZA915371B (en) Antitumor compositions and methods of treatment
HK1018271A1 (en) Substituted benzylamines and their use for the treatment of depression
EP0656069A4 (en) Inhibitors of cell proliferation, their preparation and use.
AR244941A1 (en) Compound, composition, procedure and use of an anti microbial product.
AP9200355A0 (en) "Therapeutic agent"
UA41915C2 (en) Agent for inhibiting proliferation and migration of vascular smooth muscles in mammals
ZA969586B (en) The use of cholinesterase inhibitors in the treatment of xerostomia
PL314799A1 (en) Application of dimeticone in treating constipations
HUT57806A (en) Copolymer composition comprising copolymer and one or more lubricants